BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12954630)

  • 21. Phosphorylated FADD induces NF-kappaB, perturbs cell cycle, and is associated with poor outcome in lung adenocarcinomas.
    Chen G; Bhojani MS; Heaford AC; Chang DC; Laxman B; Thomas DG; Griffin LB; Yu J; Coppola JM; Giordano TJ; Lin L; Adams D; Orringer MB; Ross BD; Beer DG; Rehemtulla A
    Proc Natl Acad Sci U S A; 2005 Aug; 102(35):12507-12. PubMed ID: 16109772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The human papillomavirus 16 E6 protein binds to Fas-associated death domain and protects cells from Fas-triggered apoptosis.
    Filippova M; Parkhurst L; Duerksen-Hughes PJ
    J Biol Chem; 2004 Jun; 279(24):25729-44. PubMed ID: 15073179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The death domain of FADD is essential for embryogenesis, lymphocyte development, and proliferation.
    Imtiyaz HZ; Zhou X; Zhang H; Chen D; Hu T; Zhang J
    J Biol Chem; 2009 Apr; 284(15):9917-26. PubMed ID: 19203997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FIST/HIPK3: a Fas/FADD-interacting serine/threonine kinase that induces FADD phosphorylation and inhibits fas-mediated Jun NH(2)-terminal kinase activation.
    Rochat-Steiner V; Becker K; Micheau O; Schneider P; Burns K; Tschopp J
    J Exp Med; 2000 Oct; 192(8):1165-74. PubMed ID: 11034606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fas-associated death domain protein interacts with methyl-CpG binding domain protein 4: a potential link between genome surveillance and apoptosis.
    Screaton RA; Kiessling S; Sansom OJ; Millar CB; Maddison K; Bird A; Clarke AR; Frisch SM
    Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5211-6. PubMed ID: 12702765
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protection against Fas-mediated and tumor necrosis factor receptor 1-mediated liver injury by blockade of FADD without loss of nuclear factor-kappaB activation.
    Seino K; Setoguchi Y; Ogino T; Kayagaki N; Akiba H; Nakano H; Taniguchi H; Takada Y; Yuzawa K; Todoroki T; Fukuchi Y; Yagita H; Okumura K; Fukao K
    Ann Surg; 2001 Nov; 234(5):681-8. PubMed ID: 11685033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of an expanded binding surface on the FADD death domain responsible for interaction with CD95/Fas.
    Hill JM; Morisawa G; Kim T; Huang T; Wei Y; Wei Y; Werner MH
    J Biol Chem; 2004 Jan; 279(2):1474-81. PubMed ID: 14573612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FADD and its phosphorylation.
    Zhang J; Zhang D; Hua Z
    IUBMB Life; 2004 Jul; 56(7):395-401. PubMed ID: 15545216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fas-associated factor 1, FAF1, is a member of Fas death-inducing signaling complex.
    Ryu SW; Lee SJ; Park MY; Jun JI; Jung YK; Kim E
    J Biol Chem; 2003 Jun; 278(26):24003-10. PubMed ID: 12702723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p53-dependent impairment of T-cell proliferation in FADD dominant-negative transgenic mice.
    Zörnig M; Hueber AO; Evan G
    Curr Biol; 1998 Apr; 8(8):467-70. PubMed ID: 9550704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Constitutive phosphorylation mutation in Fas-associated death domain (FADD) results in early cell cycle defects.
    Osborn SL; Sohn SJ; Winoto A
    J Biol Chem; 2007 Aug; 282(31):22786-92. PubMed ID: 17553783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular evidence for the nuclear localization of FADD.
    Gómez-Angelats M; Cidlowski JA
    Cell Death Differ; 2003 Jul; 10(7):791-7. PubMed ID: 12815462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of a dominant interfering mutant of FADD on signal transduction in activated T cells.
    Newton K; Kurts C; Harris AW; Strasser A
    Curr Biol; 2001 Feb; 11(4):273-6. PubMed ID: 11250157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis C virus core protein enhances FADD-mediated apoptosis and suppresses TRADD signaling of tumor necrosis factor receptor.
    Zhu N; Ware CF; Lai MM
    Virology; 2001 May; 283(2):178-87. PubMed ID: 11336543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T cell-specific FADD-deficient mice: FADD is required for early T cell development.
    Kabra NH; Kang C; Hsing LC; Zhang J; Winoto A
    Proc Natl Acad Sci U S A; 2001 May; 98(11):6307-12. PubMed ID: 11353862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1.
    Zhang J; Cado D; Chen A; Kabra NH; Winoto A
    Nature; 1998 Mar; 392(6673):296-300. PubMed ID: 9521326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Casper is a FADD- and caspase-related inducer of apoptosis.
    Shu HB; Halpin DR; Goeddel DV
    Immunity; 1997 Jun; 6(6):751-63. PubMed ID: 9208847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dominant-negative FADD inhibits TNFR60-, Fas/Apo1- and TRAIL-R/Apo2-mediated cell death but not gene induction.
    Wajant H; Johannes FJ; Haas E; Siemienski K; Schwenzer R; Schubert G; Weiss T; Grell M; Scheurich P
    Curr Biol; 1998 Jan; 8(2):113-6. PubMed ID: 9427646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Caspase- and serine protease-dependent apoptosis by the death domain of FADD in normal epithelial cells.
    Thorburn J; Bender LM; Morgan MJ; Thorburn A
    Mol Biol Cell; 2003 Jan; 14(1):67-77. PubMed ID: 12529427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of Fas-associated death domain interactions by the death effector domain identified by a modified reverse two-hybrid screen.
    Thomas LR; Stillman DJ; Thorburn A
    J Biol Chem; 2002 Sep; 277(37):34343-8. PubMed ID: 12107169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.